DSGN 8-K 2026-08-03

Design Therapeutics, Inc. (DSGN) 8-K dated 2026-08-03 — accession 0001193125-26-329570. This URL is the filing, not the DSGN hub.

Design Therapeutics, Inc. (DSGN) is a biotechnology company listed on US.

Design Therapeutics, Inc. filed a 8-K on 2026-08-03. Accession 0001193125-26-329570.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported DSGN revenue for 2025-12-31 was $0. Net income was -$69.8M. DSGN currently screens at market cap $214.0M.

Not investment advice. The DSGN SEC hub lists recent forms. The stock page is the research view.